Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

Publication | Closed Access

DOI

818

Citations

References

2010

Year

Michèle Cavo, Paola Tacchetti, Francesca Patriarca, Maria Teresa Petrucci, Lucia Pantani, Mónica Galli, Francesco Di Raimondo, Claudia Crippa, Elena Zamagni, Antonio Palumbo,

The Lancet

Hematological MalignancyTransplantationMarrow TransplantationOncologyRandomised Phase 3Stem Cell TransplantationHematologyConsolidation TherapyMultiple MyelomaCell TransplantationMedicineRadiation OncologyHealth Sciences